MOMOSA® Adaptogen‑Infused Spritzers Debut at Walmart in Utah, Arizona, California

Busty Lush has introduced a new line of non‑alcoholic spritzers on Walmart shelves in Utah, Arizona and California. This marks the brand’s first retail launch outside its tasting room and positions it within the growing low‑ABV segment that is outpacing traditional beer growth.

The launch is marketed as premium, offering six‑pack variety packs of Italian Spritz, Limoncello Spritz and Guava Bellini. Each can contains adaptogens—KSM‑66® ashwagandha, lemon balm and magnesium—and no artificial flavors, colors or sweeteners. The limited three‑state rollout indicates a cautious, data‑driven approach to gauge market reception before expanding nationwide.

The U.S. non‑alcoholic beverage market was about $3.3 billion in 2024 and is projected to grow at an 8.5% CAGR through 2030. This momentum has prompted retailers to allocate shelf space for such products, though competition remains intense. The launch follows the broader trend of functional drinks that are usually retail between $3 and $5 per can—higher than sparkling water but below many craft‑beer prices.

Walmart provides access to more than 4,700 U.S. stores, yet the limited state footprint signals a cautious, data‑driven approach. Off‑premise NA beverage sales grew 22% YoY in early 2026 versus total beer growth of 1.3%, underscoring the category’s rapid expansion.

Busty Lush is 100 % woman‑owned and has earned a reputation for premium non‑alcoholic beers and cocktails. Expanding into spritzers lets it leverage existing distribution relationships while broadening its portfolio. The Walmart launch provides access to a vast retail network, yet the three‑state test balances a higher price point against a growing category.

Retailers should monitor depletions in Utah, Arizona and California. Strong sales near the upper end of the $3–$5 range could justify a broader Walmart rollout or expansion to other national retailers. Retail buyers may find the higher price point appealing to health‑conscious shoppers seeking adaptogens; however, marketing language must remain within FDA limits on disease prevention claims.

On‑premise operators will not see this SKU in their bars; the release makes it clear that it is a retail launch, eliminating menu placement confusion. For consumers, the absence of artificial ingredients positions the spritzers as a cleaner alternative to traditional cocktails, though the price premium suggests they will appeal mainly to niche buyers rather than mass shoppers.

Busty Lush’s entry into Walmart’s three‑state test balances a higher retail price against a growing category and clear regulatory limits. The launch offers distributors a measurable signal: if depletions in Utah, Arizona and California meet expectations, it may justify scaling to other Walmart stores or partnering with additional retailers. Success will be measured by depletions, margin capture and the extent to which the adaptogen narrative resonates within FDA‑approved marketing language.